What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Stephen P. Hunger mostly deals with Internal medicine, Cancer research, Oncology, Acute lymphocytic leukemia and Childhood Acute Lymphoblastic Leukemia.
His Cancer research research incorporates themes from Genetics, Leukemia, Mutation, Tyrosine kinase and Philadelphia chromosome.
His work carried out in the field of Philadelphia chromosome brings together such families of science as Janus kinase 2, ABL and PDGFRB.
His work deals with themes such as Cancer, Clinical trial, Methotrexate, Young adult and Multivariate analysis, which intersect with Oncology.
His Acute lymphocytic leukemia research is multidisciplinary, incorporating elements of Exon, Cell cycle, Gene expression profiling and Chromosomal translocation.
The study incorporates disciplines such as Mercaptopurine, Survival rate, Case-control study, Single-nucleotide polymorphism and Acute leukemia in addition to Childhood Acute Lymphoblastic Leukemia.
His most cited work include:
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (1109 citations)
- Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. (995 citations)
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia (737 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Oncology, Cancer research, Leukemia and Acute lymphocytic leukemia.
His work in the fields of Minimal residual disease, Chemotherapy, Lymphoblastic Leukemia and Cohort overlaps with other areas such as Cog.
His Oncology research is multidisciplinary, relying on both Cancer, Clinical trial, Methotrexate, Childhood Acute Lymphoblastic Leukemia and Prednisone.
In his study, which falls under the umbrella issue of Cancer research, Dasatinib and PDGFRB is strongly linked to ABL.
The Leukemia portion of his research involves studies in Immunology and Genetics.
His studies deal with areas such as Regimen, Gene expression profiling and Chromosomal translocation as well as Acute lymphocytic leukemia.
He most often published in these fields:
- Internal medicine (52.96%)
- Oncology (41.43%)
- Cancer research (23.83%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (52.96%)
- Oncology (41.43%)
- Leukemia (21.34%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Oncology, Leukemia, Cancer research and Lymphoblastic Leukemia.
His work in the fields of Internal medicine, such as Chemotherapy, Minimal residual disease, Clinical trial and Cancer, overlaps with other areas such as Cog.
His Oncology research incorporates elements of Hematopoietic stem cell transplantation, Methotrexate, Young adult, Randomized controlled trial and Group study.
His Cancer research research includes themes of T cell, Transcription factor and Cell culture.
His Lymphoblastic Leukemia research is multidisciplinary, incorporating perspectives in Treatment outcome, Down syndrome and Pediatrics.
In Acute lymphocytic leukemia, Stephen P. Hunger works on issues like Childhood Acute Lymphoblastic Leukemia, which are connected to Genotype and Genome-wide association study.
Between 2017 and 2021, his most popular works were:
- Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours (268 citations)
- PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia (105 citations)
- The genetic basis and cell of origin of mixed phenotype acute leukaemia (86 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Stephen P. Hunger mainly focuses on Internal medicine, Oncology, Chemotherapy, Cancer research and Lymphoblastic Leukemia.
Internal medicine is closely attributed to Gastroenterology in his work.
His research in Oncology intersects with topics in Clinical trial, Young adult, Randomized controlled trial, Philadelphia chromosome and Leukemia.
His studies in Chemotherapy integrate themes in fields like Proteasome inhibitor, Proteasome Inhibition and Bone marrow, Minimal residual disease.
The Cancer research study combines topics in areas such as Cell growth, Phenotype, T cell, Apoptosis and Transcription factor.
When carried out as part of a general Lymphoblastic Leukemia research project, his work on Asparaginase is frequently linked to work in Extramural and Text mining, therefore connecting diverse disciplines of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
